Medicamen Biotech Ltd Q4 FY2024-2025 Results: Summary
Revenue | ₹34.84Cr |
Net Profits | ₹2.42Cr |
Net Profit Margins | 6.95% |
Medicamen Biotech Ltd’s revenue fell -27.25% since last year same period to ₹34.84Cr in the Q4 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated -23.06% fall in its revenue since last 3-months.
Medicamen Biotech Ltd’s net profit jumped 13.62% since last year same period to ₹2.42Cr in the Q4 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated -30.26% fall in its net profits since last 3-months.
Medicamen Biotech Ltd’s net profit margin jumped 56.17% since last year same period to 6.95% in the Q4 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated -9.36% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Medicamen Biotech Ltd in Q4 results 2024?
The revenue for Medicamen Biotech Ltd in the Q4 results 2024 was ₹34.84Cr.
What was the net profit for Medicamen Biotech Ltd in Q4 results 2024?
The net profit for Medicamen Biotech Ltd in the Q4 results 2024 was ₹2.42Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q4 results 2024?
The net profit margin for Medicamen Biotech Ltd in the Q4 results 2024 was 6.95%.
What was the revenue for Medicamen Biotech Ltd in Q4 results 2023?
The revenue for Medicamen Biotech Ltd in the Q4 results 2023 was ₹47.89Cr.
What was the net profit for Medicamen Biotech Ltd in Q4 results 2023?
The net profit for Medicamen Biotech Ltd in the Q4 results 2023 was ₹2.13Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q4 results 2023?
The net profit margin for Medicamen Biotech Ltd in the Q4 results 2023 was 4.45%.
